Peptide Stack
CJC-1295 + ipamorelin stack
A recovery and performance stack commonly used to support growth-hormone signaling, sleep quality, and body-composition goals.
In depth
Why these two are paired
CJC-1295 and ipamorelin act on two different pituitary receptors — CJC-1295 through the GHRH receptor, ipamorelin through the ghrelin receptor — that converge on the same GH-releasing somatotroph cells. Pairing a GHRH analog with a ghrelin-receptor agonist is the standard rationale given for combining the two.
What's actually established vs. assumed
Each half of this stack has its own human pharmacology data collected separately — CJC-1295 in a 2006 healthy-adult trial, ipamorelin in earlier selectivity research — but the combination itself has not been studied together in a controlled human trial. The larger-GH-pulse rationale is extrapolated from the two receptors' separate mechanisms, not directly demonstrated for the pairing.
Safety
Because both compounds drive the same downstream GH/IGF-1 axis, side effects tend to be additive rather than novel: water retention, flushing, headache, and injection-site reactions. Neither compound is FDA approved individually, and the stack inherits that unregulated status.
Detail
Overview
A recovery and performance stack commonly used to support growth-hormone signaling, sleep quality, and body-composition goals.
Benefits, side effects, and protocols
Benefits list
Side effects
Vendor protocol
- None listed
Clinical protocol
- None listed
Evidence
- Low
Regulatory
- Not Fda Approved
Research
Mechanisms
Evidence notes
- Low
Administration
Research links
Contraindications
- None listed
Components
Regulatory data
- Not Fda Approved
Aliases
- None listed
Related compounds
Frequently asked questions
What is the CJC-1295 and ipamorelin stack used for?
It is commonly discussed for GH-axis support, recovery, sleep quality, and body-composition goals, combining a GHRH analog with a ghrelin-receptor agonist.
Does combining CJC-1295 and ipamorelin work better than either alone?
The mechanistic case — two different receptors converging on the same GH pulse — is well described in secretagogue research, but the specific combination has not been tested against either compound alone in a controlled trial.
Is the CJC-1295 and ipamorelin stack FDA approved?
No — neither individual compound is FDA approved, and the combination has not been evaluated by any regulatory body.
Educational reference only. Pepperz does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing recommendations. Sourcing CJC-1295 + ipamorelin stack? Check your source before you use anything.